← Back to Search

Mapping and Biopsy Study for Kidney Stones

N/A
Recruiting
Led By James Lingeman, MD
Research Sponsored by Indiana Kidney Stone Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Upper urinary tract endoscopic or PERC procedure for kidney stones removal
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year from study completion
Awards & highlights

Study Summary

This trial will study Randall's plaques in patients with kidney stones to better understand what causes kidney stones.

Who is the study for?
This trial is for people in good health who need surgery to remove kidney stones or treat other urologic conditions at Methodist Urology in Indianapolis, IN. Participants must be able to complete all study requirements and sign a consent form. Those with bleeding disorders, poor health, or unable to follow post-surgery instructions cannot join.Check my eligibility
What is being tested?
The study aims to better understand kidney stone causes by examining the papilla (kidney areas where stones attach) during surgery. It involves videotaping renal anatomy and taking papillary biopsies from patients undergoing stone removal procedures.See study design
What are the potential side effects?
Since this trial involves standard surgical procedures for kidney stone removal, side effects may include typical surgical risks such as pain, infection risk at the biopsy site, bleeding, and potential complications related to anesthesia.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have had a procedure to remove kidney stones using endoscopy or PERC.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year from study completion
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year from study completion for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
To find out why people form stones by comparing 24 urine collections, biopsy and anatomy to other patients who do not form stones and other patients who do form stones to see if the differences are significant

Trial Design

1Treatment groups
Experimental Treatment
Group I: cohortExperimental Treatment1 Intervention
Subjects who are scheduled to undergo a percutaneous kidney stone removal who do not have complicated comorbidities

Find a Location

Who is running the clinical trial?

Indiana University School of MedicineOTHER
185 Previous Clinical Trials
142,232 Total Patients Enrolled
University of ChicagoOTHER
997 Previous Clinical Trials
817,098 Total Patients Enrolled
Indiana Kidney Stone InstituteLead Sponsor
15 Previous Clinical Trials
5,585 Total Patients Enrolled

Media Library

cohort Clinical Trial Eligibility Overview. Trial Name: NCT00169806 — N/A
Cystinuria Research Study Groups: cohort
Cystinuria Clinical Trial 2023: cohort Highlights & Side Effects. Trial Name: NCT00169806 — N/A
cohort 2023 Treatment Timeline for Medical Study. Trial Name: NCT00169806 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment currently available for this clinical research?

"According to the information on clinicaltrials.gov, this particular research endeavor is in need of participants. This trial was initially activated on November 1st 1998 and most recently updated on January 18th 2022."

Answered by AI

What is the highest number of individuals that can take part in this experiment?

"Affirmative, per the details available on clinicaltrials.gov this investigation is presently accepting participants. This trial was first posted on November 1st 1998 and updated most recently on January 18th 2022. 600 individuals need to be recruited across one medical site."

Answered by AI
~37 spots leftby Dec 2025